Novo Nordisk
NVO
491 hedge funds and large institutions have $7.6B invested in Novo Nordisk in 2017 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 141 increasing their positions, 187 reducing their positions, and 35 closing their positions.
66% more call options, than puts
Call options by funds: $30.4M | Put options by funds: $18.3M
55% more funds holding in top 10
Funds holding in top 10: 11 → 17 (+6)
40% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 35
15% more capital invested
Capital invested by funds: $6.59B → $7.6B (+$1.01B)
1% more funds holding
Funds holding: 484 → 491 (+7)
0.42% more ownership
Funds ownership: 15.67% → 16.09% (+0.42%)
25% less repeat investments, than reductions
Existing positions increased: 141 | Existing positions reduced: 187
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$130M |
| 2 |
BlackRock
New York
|
+$60.9M |
| 3 |
Renaissance Technologies
New York
|
+$37.4M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$26.1M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$21.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$45.5M |
| 2 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
-$33.4M |
| 3 |
Two Sigma Advisers
New York
|
-$29.8M |
| 4 |
SBAM
Santa Barbara Asset Management
Los Angeles,
California
|
-$15.9M |
| 5 |
CBT
Capital Bank & Trust
Irvine,
California
|
-$11.5M |
NVO Hedge Fund Activity: Q3 2017 in Review
491 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q3 2017, worth a combined $7.6B — up 15% from $6.59B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new NVO positions and 35 closed out — a net gain of 14 holders — while 141 added to existing stakes and 187 trimmed.
The largest buyer was Bank of America, adding an estimated $130M. The largest seller was Credit Suisse, exiting entirely with an estimated $45.5M sold.
- 491 institutional investors held Novo Nordisk (NVO) as of Q3 2017, up from 484 in Q2 2017.
- Funds reported $7.6B of Novo Nordisk stock for Q3 2017, up 15% quarter-over-quarter.
- 49 funds opened new Novo Nordisk positions in Q3 2017 and 35 closed out, a net change of +14 holders.
- The largest Novo Nordisk buyer in Q3 2017 was Bank of America, an estimated $130M added.
- The largest Novo Nordisk seller in Q3 2017 was Credit Suisse, an estimated $45.5M sold.
Based on aggregated 13F filings for Q3 2017.